(Jyllinge, Denmark) AddiFab, a developer and provider of both 3D-printers and materials, today announced that it has received an investment from Diamond Edge Ventures, Inc. (DEV) the U.S. venture capital arm of Mitsubishi Chemical Holdings Corporation (MCHC) established in 2018.
AddiFab is pioneering Freeform Injection Molding (FIM) – a transformative platform that brings the entire range of materials from the injection molding industry into the world of additive manufacturing. With Freeform Injection Molding, additive manufacturers will no longer need to compromise on the selection of materials or on product complexity. Backed by real life data, AddiFab has shown that FIM is equally well suited for the processing of rubbers, thermoplastics, ceramics and hard metals, and the list of compatible materials grows every week. A wide range of high-performance polymers from Mitsubishi Chemical have already been Qualified for FIM™
“Our investment in AddiFab reflects MCHC’s dedication to the 3D printing community”, says Patrick Suel, President of DEV. “FIM gives customers the flexibility and speed of 3D Printing with the consistence and reliability of Injection Molding. The industry can now rely on an existing and independent supply chain of existing and proven materials. We have already brought the tried and trusted materials from the DIAKON®, KyronMAX™, Ketron®, Tefabloc™ and Trexprene™ into the additive world created by FIM, and more will follow as a result of this collaboration”.
As part of the investment, Patrick Suel, a veteran venture capitalist will join the AddiFab’s Board of Directors.
The investment follows a period of increasing collaboration between Mitsubishi Chemical and AddiFab. “This investment and development relationship with the MCHC Group companies, a world-wide leader in advanced, high-performance polymer materials, will strengthen the ecosystem of support for AddiFab and their customers for the global deployment of Freeform Injection Molding” says Lasse Staal, AddiFab co-founder and CEO. “The collaboration with Mitsubishi Chemical will allow us to strengthen the Freeform Injection Platform while at the same time accelerating the pace of adoption of this transformative technology.”
AddiFab develops and delivers 3D-printers, post-processing equipment, software and materials to the manufacturing industry already today. Freeform Injection Molding – the company’s flagship platform – combines the short lead-times, low start-up costs and design freedom from additive manufacturing with the scalability and wide range of materials from injection molding. This enables customers to dramatically shorten times-to-launch, increase customization levels and reduce supply chain complexity. AddiFab has offices in both Jyllinge, Denmark and in Palo Alto, Silicon Valley in the United States. For more information about AddiFab, visit www.addifab.com
About Mitsubishi Chemical Holdings Corporation
Mitsubishi Chemical Holdings conducts its corporate activities and businesses worldwide in the domains of Performance Products, Industrial Materials, and Health Care based on the three decision-making criteria of "Sustainability," "Health," and "Comfort." The company will create sustainable corporate value and be a trusted company to its stakeholders by contributing to the sustainable development of people, society, and the Earth. For more information on the company, visit http://www.mitsubishichem-hd.co.jp/english/
About Diamond Edge Ventures
Diamond Edge Ventures, Inc (“DEV”), a wholly-owned subsidiary of Mitsubishi Chemical Holdings Corporation (“MCHC”), was established in July 2018 as the Corporate Venture Capital arm of the Group. DEV’s mission is to foster innovation across MCHC’s group companies by investing in and partnering with strategic startups. Led by experienced Silicon Valley Venture Capitalists and Serial Entrepreneurs, DEV is building a strong ecosystem built on competence, trust, and added value.